+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Long-term depot maintenance of chronic schizophrenic out-patients: the seven year follow-up of the Medical Research Council fluphenazine/placebo trial I. Course of illness, stability of diagnosis, and the role of a special maintenance clinic



Long-term depot maintenance of chronic schizophrenic out-patients: the seven year follow-up of the Medical Research Council fluphenazine/placebo trial I. Course of illness, stability of diagnosis, and the role of a special maintenance clinic



British Journal of Psychiatry 146: 464-469



A follow-up study of all patients entering the MRC double-blind trial of fluphenazine decanoate in chronic schizophrenic out-patients achieved a trace rate of 94%. In general, these patients were severely disabled, continued under the care of the maintenance clinic, and their diagnoses remained remarkably consistent; more than one-fifth were found to be in acute schizophrenic relapse and in over a half of these cases, the relapse was not known to the treatment agency. The maintenance clinic attenders were little different from those who no longer used such a facility.

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 040596593

Download citation: RISBibTeXText

PMID: 3893598


Related references

Long term depot maintenance of chronic schizophrenic outpatients the 7 year follow up of the medical research council fluphenazine placebo trial 1. course of illness stability of diagnosis and the role of a special maintenance clinic. British Journal of Psychiatry 146(MAY): 464-480, 1985

Long-term depot maintenance of chronic schizophrenic out-patients: the seven year follow-up of the Medical Research Council fluphenazine/placebo trial. II. The incidence of compliance problems, side-effects, neurotic symptoms and depression. British Journal of Psychiatry 146: 469-474, 1985

Long-term depot maintenance of chronic schizophrenic out-patients: the seven year follow-up of the Medical Research Council fluphenazine/placebo trial. III. Relapse postponement or relapse prevention? The implications for long-term outcome. British Journal of Psychiatry 146: 474-480, 1985

Outpatient maintenance of chronic schizophrenic patients with long-acting fluphenazine: double-blind placebo trial. Report to the Medical Research Council Committee on Clinical Trials in Psychiatry. British Medical Journal 1(5854): 633-637, 1973

Outpatient Maintenance of Chronic Schizophrenic Patients with Long-acting Fluphenazine: Double-blind Placebo. BMJ 1(5854): 633-637, 1973

Long-term fluphenazine decanoate maintenance dosage requirements of chronic schizophrenic patients. Acta Psychiatrica Scandinavica 61(3): 256-262, 1980

I. Course of Illness, Stability of Diagnosis, and the Role of a Special Maintenance Clinic. British Journal of Psychiatry 146(5): 464-469, 1985

Effects of induction and maintenance plus long-term bisphosphonates on bone disease in patients with multiple myeloma: the Medical Research Council Myeloma IX Trial. Blood 119(23): 5374-5383, 2012

The long-term maintenance treatment of schizophrenic out-patients with depot flupenthixol. Current Medical Research and Opinion 1(7): 423-426, 1973

Radioimmunoassay for 7-hydroxy metabolite of fluphenazine and its application to plasma level monitoring in schizophrenic patients treated long term with oral and depot fluphenazine. Therapeutic Drug Monitoring 16(1): 21-29, 1994

When and how to withdraw or reduce the long term maintenance anti psychotic medication for chronic schizophrenic patients a research strategy. Bulletin of the Seishin-Igaku Institute (22): 125-132, 1979, 1982

Maintenance treatment of chronic schizophrenic patients. A study with the long-acting thioxanthene derivative, cis(Z)-clopenthixol decanoate-sordinol depot. Acta Psychiatrica Scandinavica 57(4): 299-304, 1978

Medication maintenance of chronic schizophrenic out-patients by a psychiatric clinical pharmacist: 10-year follow-up study. Journal of Clinical Pharmacy and Therapeutics 18(3): 183-186, 1993

Long-term outcome of depot neuroleptic maintenance treatment among chronic psychotic patients. Acta Psychiatrica Scandinavica. 96(5): 347-353,., 1997

Quality of life in schizophrenia: Long-term follow-up in 362 chronic Spanish schizophrenic outpatients undergoing risperidone maintenance treatment. European Psychiatry 13(3): 158-163, 1998